Seleccione un Tamaño
| A ustedes/SKU | Disponibilidad | Precio |
|---|---|---|
0.2 mL | 0 left in stock | $489.00 |
Acerca de este artículo
biological source
mouse
Quality Segment
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
FG9-77, monoclonal
form
buffered aqueous solution
mol wt
antigen 25 kDa
species reactivity
mouse, human
technique(s)
dot blot: 5 μg/mL using recombinant human FGF-9, indirect ELISA: suitable, microarray: suitable, western blot: suitable
isotype
IgG1
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... FGF9(2254)
mouse ... Fgf9(14180)
General description
Immunogen
Application
Immunohistochemistry (1 paper)
Biochem/physiol Actions
Physical form
Disclaimer
1 of 1
Este artículo | |||
|---|---|---|---|
| clone FG9-77, monoclonal | clone FB-8, monoclonal | clone 3H2, monoclonal | clone 2A11, monoclonal |
| Gene Information human ... FGF9(2254) | Gene Information human ... FGF2(2247) | Gene Information human ... FGF8(2253) | Gene Information human ... FGF8(2253) |
| species reactivity mouse, human | species reactivity bovine, human | species reactivity human | species reactivity human |
| biological source mouse | biological source mouse | biological source mouse | biological source mouse |
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate unconjugated |
| antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified immunoglobulin |
Still not finding the right product?
Pruebe nuestra Herramienta de selección de productos para limitar sus opciones
Clase de almacenamiento
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.



